P-088 - ADDITION OF PHARMACOGENE VARIANTS TO CLINICAL RISK FACTORS (e.g. HAS-BLED SCORE) IMPROVES BLEEDING RISK PREDICTION FOR PATIENTS ON RIVAROXABAN.

I. Lee, M. Ban, B. Ryu, Y. Youn, M. Kim, J. Chiang; Cipherome Inc., San Jose, CA, USA.

Presenting Author(s)

In Gu Lee, MD

Data Science Manager
Cipherome Inc.
San Jose, California, United States